![Paul Sargeant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Paul Sargeant is a President, Chief Executive Officer & Director at Circular Genomics, Inc. He is on the Board of Directors at Circular Genomics, Inc. Dr. Sargeant was previously employed as a Chief Executive Officer by Rebus Biosystems, Inc. He received his doctorate degree from the University of Cambridge.
| Sociétés | Poste | Début |
|---|---|---|
Circular Genomics, Inc.
 Circular Genomics, Inc. BiotechnologyHealth Technology Operates as a biotechnology and genomics company that develops RNA-based diagnostics and therapeutics | Directeur Général | 01/02/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
Rebus Biosystems, Inc.
 Rebus Biosystems, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a life science technology company | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rebus Biosystems, Inc.
Rebus Biosystems, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a life science technology company | Commercial Services |
Circular Genomics, Inc.
Circular Genomics, Inc. BiotechnologyHealth Technology Operates as a biotechnology and genomics company that develops RNA-based diagnostics and therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
